From Our Partners
Thursday, July 7, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

FLIR Receives 51M Order for DoD CBRNE Program

by Global Biodefense Staff
April 9, 2015
CBRN News on Global Biodefense

FLIR Systems, Inc. announced today that it has received the second full-rate production order under a five-year indefinite delivery, indefinite quantity contract from the U.S. Department of Defense to support the Nuclear, Biological, and Chemical Dismounted Reconnaissance Sets, Kits, and Outfits (DR SKO) program.

The contract is for FLIR’s integrated chemical, biological, radiological, nuclear, and explosives (CBRNE) threat response system and related spares and services. The follow-on order is for systems totaling $51.1 million.

The DR SKO program, in development since 2008, is a joint-service, Department of Defense initiative centered on CBRNE threat detection systems that will be utilized by the Army, Navy, Air Force, Marines, and Civil Support Teams. The FLIR DR SKO system provides an integrated set of CBRNE detection, identification, sample collection, testing, and personal safety kits that allow personnel to perform site assessment and consequence management missions.

“Our continued success under the DR SKO program is the result of FLIR’s commitment to product execution and customer support,” said Andy Teich, President and CEO of FLIR. “We are pleased to support the U.S. Government with these integrated systems that are designed to protect people against serious threats.”

Production under the contract is expected to be performed out of FLIR’s facility in Elkridge, MD, and fulfillment of the delivery order is expected to occur from September 2015 through April 2016.

From Our Partners
Tags: Chemical DetectionCollective ProtectionMobile Response

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Biodefense Headlines – 5 July 2022

Biodefense Headlines – 5 July 2022

July 5, 2022
Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC